Agios Pharmaceuticals, Inc. Earnings

Agios Pharmaceuticals, Inc.’s revenue jumped 21.15% since last year same period to $8.96Mn in the Q3 2024. On a quarterly growth basis, Agios Pharmaceuticals, Inc. has generated 4.05% jump in its revenue since last 3-months.

Agios Pharmaceuticals, Inc.’s net profit jumped 1137.97% since last year same period to $947.92Mn in the Q3 2024. On a quarterly growth basis, Agios Pharmaceuticals, Inc. has generated 1086.2% jump in its net profits since last 3-months.

Agios Pharmaceuticals, Inc.’s net profit margin jumped 956.75% since last year same period to 10574.69% in the Q3 2024. On a quarterly growth basis, Agios Pharmaceuticals, Inc. has generated 1047.8% jump in its net profit margins since last 3-months.

Agios Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.11 - a 169.38% jump from last quarter’s estimates.

Agios Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at 1.11.

Agios Pharmaceuticals, Inc.’s earning per share (EPS) fell -47.56% since last year same period to -2.42 in the Q3 2024. This indicates that the Agios Pharmaceuticals, Inc. has generated -47.56% annual rate of fall in its earning per share (EPS) in the last 4 quarters.